-
Mashup Score: 119
The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.’s business for stockholders, potential investors, and financial analysts.
Source: ir.ionis.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 116
The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.’s business for stockholders, potential investors, and financial analysts.
Source: ir.ionis.comCategories: General Medicine News, CardiologistsTweet-
Breaking news for the lipid community: the FDA has approved Ionis’ medicine – the first and only treatment for adults with FCS in the U.S. as an adjunct to diet. Proud to be part of a determined, dedicated team. Read more: https://t.co/pXIK54siw6 https://t.co/HAfk8gZQIM
-
-
Mashup Score: 16Resources & Education for Patients with sHTG | KnowYourTGs - 15 day(s) ago
Knowyourtgs.com is a resource for those with Severe Hypertriglyceridemia (sHTG), and genetic forms such as Familial Chylomicronemia Syndrome (FCS).
Source: www.knowyourtgs.comCategories: General Medicine News, CardiologistsTweet-
RT @ionispharma: HCPs: https://t.co/6gvjb0lrIi is a patient resource offering comprehensive information about familial chylomicronemia synd…
-
-
Mashup Score: 51ClinicalTrials.gov - 1 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
No Phase 3 Lp(a) HORIZON started in 2019, and is estimated to read out in 2025. We are almost there...https://t.co/WPN2GejTKH https://t.co/GU4VjeIPnX https://t.co/FZ6zvdbZMW
-
-
Mashup Score: 188Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis - PubMed - 1 month(s) ago
The LPA gene is the only monogenetic risk factor for calcific aortic valve stenosis (CAVS). Oxidized phospholipids (OxPL) and lysophosphatidic acid generated by autotaxin (ATX) from OxPL are pro-inflammatory. Aortic valve leaflets were categorized pathologically from Both ATX-apoB and ATX-apo …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
Yes-https://t.co/lXTdpjyLCs https://t.co/1DRidd2g4Q https://t.co/YwwZfsPnrv
-
-
Mashup Score: 51ClinicalTrials.gov - 1 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
No Phase 3 Lp(a) HORIZON started in 2019, and is estimated to read out in 2025. We are almost there...https://t.co/WPN2GejTKH https://t.co/GU4VjeIPnX https://t.co/FZ6zvdbZMW
-
-
Mashup Score: 182Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis - PubMed - 1 month(s) ago
The LPA gene is the only monogenetic risk factor for calcific aortic valve stenosis (CAVS). Oxidized phospholipids (OxPL) and lysophosphatidic acid generated by autotaxin (ATX) from OxPL are pro-inflammatory. Aortic valve leaflets were categorized pathologically from Both ATX-apoB and ATX-apo …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
Yes-https://t.co/lXTdpjyLCs https://t.co/1DRidd2g4Q https://t.co/YwwZfsPnrv
-
-
Mashup Score: 58Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial - PubMed - 1 month(s) ago
ClinicalTrials.gov Identifier: NCT05563246.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
There is now data on @OxPL_apoB and OxPL-apo(a) with oral muvalaplin Lp(a) drug (measured @UCSDCardiology). @UCSDCardFellows https://t.co/TcFtUzyzHP https://t.co/e7CSR7db9U
-
-
Mashup Score: 58Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial - PubMed - 1 month(s) ago
ClinicalTrials.gov Identifier: NCT05563246.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
There is now data on @OxPL_apoB and OxPL-apo(a) with oral muvalaplin Lp(a) drug (measured @UCSDCardiology). @UCSDCardFellows https://t.co/TcFtUzyzHP https://t.co/e7CSR7db9U
-
-
Mashup Score: 22High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low - 1 month(s) ago
While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
Here is an interview on the paper @TCTMD It is more suited for lay audience, so good source for interpreting the data. @hsbhatia https://t.co/ojwEQ7Xuof https://t.co/lUFXvoplZd
-
Breaking news for the lipid community: the FDA has approved Ionis’ medicine – the first and only treatment for adults with FCS in the U.S. as an adjunct to diet. Proud to be part of a determined, dedicated team. Read more: https://t.co/pXIK54siw6 https://t.co/HAfk8gZQIM